The WACC of Stemsation International Inc (STSN) is 5.2%.
Range | Selected | |
Cost of equity | 5.4% - 6.8% | 6.1% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 4.7% - 5.6% | 5.2% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.33 | 0.34 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.4% | 6.8% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.61 | 0.61 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 4.7% | 5.6% |
Selected WACC | 5.2% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
STSN | Stemsation International Inc | 0.61 | -2.38 | -1.65 |
DROP | Fuse Science Inc | 1.28 | 1.29 | 0.67 |
GRCU | Green Cures & Botanical Distribution Inc | 3.83 | 0.31 | 0.08 |
JOEY | Joey New York Inc | 106.89 | 0 | 0 |
MIMI.V | Mimi's Rock Corp | 1.89 | 0.41 | 0.17 |
NUUU | Rejuvel Bio-Sciences Inc | 307 | 0 | 0 |
NUVM | NuVim Inc | 0.48 | -0.9 | -0.67 |
TDNT | Trident Brands Inc | 5976.95 | -1.27 | 0 |
VPI.V | Vitality Products Inc | 0 | -0.93 | -0.93 |
YGYI | Youngevity International Inc | 67.57 | 0.95 | 0.02 |
Low | High | |
Unlevered beta | 0 | 0.01 |
Relevered beta | 0 | 0.01 |
Adjusted relevered beta | 0.33 | 0.34 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for STSN:
cost_of_equity (6.10%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.33) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.